Review



rabbit anti p p38 mapk monoclonal antibody  (Cell Signaling Technology Inc)


Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc rabbit anti p p38 mapk monoclonal antibody
    Rabbit Anti P P38 Mapk Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti p p38 mapk monoclonal antibody/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti p p38 mapk monoclonal antibody - by Bioz Stars, 2024-12
    86/100 stars

    Images



    Similar Products

    86
    Proteintech rabbit anti p p38 mapk thr180 tyr182
    List of antibodies
    Rabbit Anti P P38 Mapk Thr180 Tyr182, supplied by Proteintech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti p p38 mapk thr180 tyr182/product/Proteintech
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti p p38 mapk thr180 tyr182 - by Bioz Stars, 2024-12
    86/100 stars
      Buy from Supplier

    86
    ABclonal Biotechnology anti p p38 mapk
    Smpd3 mediates osteogenic differentiation of BMSCs through autophagy. a After pretreatment with 50 μmol/L GW4869 (Smpd3 inhibitor) for 1 h to inhibit Smpd3 in the presence or absence of CQ. b Treatment with 5 μmol/L GW4869 and Smpd3 knockdown lentivirus inhibited Smpd3 expression, and LC3 puncta were assessed using immunofluorescence analysis. Smpd3 inhibition reduced the formation of LC3 puncta (green dots in the figure). c Overexpression of Smpd3 increased autophagic flux. Smpd3 knockdown downregulated LC3 and upregulated P62, while overexpression of Smpd3 upregulated LC3 and downregulated P62. d Direct overexpression of Smpd3 can induce 50 μmol/L MCQ to inhibit LC3 autophagic flux and increase LC3 puncta. e Smpd3 knockdown inhibited the expression of <t>p-p38</t> MAPK induced by 1xEBSS (autophagy inducer), while overexpression of Smpd3 activated the expression of p-p38 MAPK induced by 1xEBSS. f Smpd3 knockdown activated 1xEBSS-induced p-p38 MAPK expression, while overexpression of Smpd3 inhibited 1xEBSS-induced p-p38 MAPK expression. g , h After activation of autophagy with 1xEBSS, shSmpd3 increased bone formation at 7 days and ARS staining at 14 days. i , j There was no significant difference in ALP and calcium ion levels between the osteogenic induction group and the siControl group at 3 days and 14 days. k – n After inhibition of autophagy by 50 μmol/L CQ, Smpd3 overexpression increased in ALP staining at 7 days of bone induction and ARS staining at 14 days of bone induction, with significant difference in ALP quantification and calcium ion quantification at 3 days of bone induction compared to those of the vector group. o Smpd3-mediated autophagic induction is achieved by activating p38 MAPK, inhibiting mTOR and promoting osteogenic differentiation of BMSCs by inducing autophagy (scale bar = 50 μm, * P < 0.05, ** P < 0.01, *** P < 0.001, *** *P < 0.000 1 using one-way ANOVA and Student-Newman-Keuls test)
    Anti P P38 Mapk, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti p p38 mapk/product/ABclonal Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti p p38 mapk - by Bioz Stars, 2024-12
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc rabbit anti p p38 mapk monoclonal antibody
    Smpd3 mediates osteogenic differentiation of BMSCs through autophagy. a After pretreatment with 50 μmol/L GW4869 (Smpd3 inhibitor) for 1 h to inhibit Smpd3 in the presence or absence of CQ. b Treatment with 5 μmol/L GW4869 and Smpd3 knockdown lentivirus inhibited Smpd3 expression, and LC3 puncta were assessed using immunofluorescence analysis. Smpd3 inhibition reduced the formation of LC3 puncta (green dots in the figure). c Overexpression of Smpd3 increased autophagic flux. Smpd3 knockdown downregulated LC3 and upregulated P62, while overexpression of Smpd3 upregulated LC3 and downregulated P62. d Direct overexpression of Smpd3 can induce 50 μmol/L MCQ to inhibit LC3 autophagic flux and increase LC3 puncta. e Smpd3 knockdown inhibited the expression of <t>p-p38</t> MAPK induced by 1xEBSS (autophagy inducer), while overexpression of Smpd3 activated the expression of p-p38 MAPK induced by 1xEBSS. f Smpd3 knockdown activated 1xEBSS-induced p-p38 MAPK expression, while overexpression of Smpd3 inhibited 1xEBSS-induced p-p38 MAPK expression. g , h After activation of autophagy with 1xEBSS, shSmpd3 increased bone formation at 7 days and ARS staining at 14 days. i , j There was no significant difference in ALP and calcium ion levels between the osteogenic induction group and the siControl group at 3 days and 14 days. k – n After inhibition of autophagy by 50 μmol/L CQ, Smpd3 overexpression increased in ALP staining at 7 days of bone induction and ARS staining at 14 days of bone induction, with significant difference in ALP quantification and calcium ion quantification at 3 days of bone induction compared to those of the vector group. o Smpd3-mediated autophagic induction is achieved by activating p38 MAPK, inhibiting mTOR and promoting osteogenic differentiation of BMSCs by inducing autophagy (scale bar = 50 μm, * P < 0.05, ** P < 0.01, *** P < 0.001, *** *P < 0.000 1 using one-way ANOVA and Student-Newman-Keuls test)
    Rabbit Anti P P38 Mapk Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti p p38 mapk monoclonal antibody/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti p p38 mapk monoclonal antibody - by Bioz Stars, 2024-12
    86/100 stars
      Buy from Supplier

    86
    Affinity Biosciences mapk p p38 antibody
    Smpd3 mediates osteogenic differentiation of BMSCs through autophagy. a After pretreatment with 50 μmol/L GW4869 (Smpd3 inhibitor) for 1 h to inhibit Smpd3 in the presence or absence of CQ. b Treatment with 5 μmol/L GW4869 and Smpd3 knockdown lentivirus inhibited Smpd3 expression, and LC3 puncta were assessed using immunofluorescence analysis. Smpd3 inhibition reduced the formation of LC3 puncta (green dots in the figure). c Overexpression of Smpd3 increased autophagic flux. Smpd3 knockdown downregulated LC3 and upregulated P62, while overexpression of Smpd3 upregulated LC3 and downregulated P62. d Direct overexpression of Smpd3 can induce 50 μmol/L MCQ to inhibit LC3 autophagic flux and increase LC3 puncta. e Smpd3 knockdown inhibited the expression of <t>p-p38</t> MAPK induced by 1xEBSS (autophagy inducer), while overexpression of Smpd3 activated the expression of p-p38 MAPK induced by 1xEBSS. f Smpd3 knockdown activated 1xEBSS-induced p-p38 MAPK expression, while overexpression of Smpd3 inhibited 1xEBSS-induced p-p38 MAPK expression. g , h After activation of autophagy with 1xEBSS, shSmpd3 increased bone formation at 7 days and ARS staining at 14 days. i , j There was no significant difference in ALP and calcium ion levels between the osteogenic induction group and the siControl group at 3 days and 14 days. k – n After inhibition of autophagy by 50 μmol/L CQ, Smpd3 overexpression increased in ALP staining at 7 days of bone induction and ARS staining at 14 days of bone induction, with significant difference in ALP quantification and calcium ion quantification at 3 days of bone induction compared to those of the vector group. o Smpd3-mediated autophagic induction is achieved by activating p38 MAPK, inhibiting mTOR and promoting osteogenic differentiation of BMSCs by inducing autophagy (scale bar = 50 μm, * P < 0.05, ** P < 0.01, *** P < 0.001, *** *P < 0.000 1 using one-way ANOVA and Student-Newman-Keuls test)
    Mapk P P38 Antibody, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mapk p p38 antibody/product/Affinity Biosciences
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mapk p p38 antibody - by Bioz Stars, 2024-12
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc p p38 mapk
    Smpd3 mediates osteogenic differentiation of BMSCs through autophagy. a After pretreatment with 50 μmol/L GW4869 (Smpd3 inhibitor) for 1 h to inhibit Smpd3 in the presence or absence of CQ. b Treatment with 5 μmol/L GW4869 and Smpd3 knockdown lentivirus inhibited Smpd3 expression, and LC3 puncta were assessed using immunofluorescence analysis. Smpd3 inhibition reduced the formation of LC3 puncta (green dots in the figure). c Overexpression of Smpd3 increased autophagic flux. Smpd3 knockdown downregulated LC3 and upregulated P62, while overexpression of Smpd3 upregulated LC3 and downregulated P62. d Direct overexpression of Smpd3 can induce 50 μmol/L MCQ to inhibit LC3 autophagic flux and increase LC3 puncta. e Smpd3 knockdown inhibited the expression of <t>p-p38</t> MAPK induced by 1xEBSS (autophagy inducer), while overexpression of Smpd3 activated the expression of p-p38 MAPK induced by 1xEBSS. f Smpd3 knockdown activated 1xEBSS-induced p-p38 MAPK expression, while overexpression of Smpd3 inhibited 1xEBSS-induced p-p38 MAPK expression. g , h After activation of autophagy with 1xEBSS, shSmpd3 increased bone formation at 7 days and ARS staining at 14 days. i , j There was no significant difference in ALP and calcium ion levels between the osteogenic induction group and the siControl group at 3 days and 14 days. k – n After inhibition of autophagy by 50 μmol/L CQ, Smpd3 overexpression increased in ALP staining at 7 days of bone induction and ARS staining at 14 days of bone induction, with significant difference in ALP quantification and calcium ion quantification at 3 days of bone induction compared to those of the vector group. o Smpd3-mediated autophagic induction is achieved by activating p38 MAPK, inhibiting mTOR and promoting osteogenic differentiation of BMSCs by inducing autophagy (scale bar = 50 μm, * P < 0.05, ** P < 0.01, *** P < 0.001, *** *P < 0.000 1 using one-way ANOVA and Student-Newman-Keuls test)
    P P38 Mapk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p p38 mapk/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    p p38 mapk - by Bioz Stars, 2024-12
    86/100 stars
      Buy from Supplier

    86
    Millipore p p38 mapk
    Human FM explants from 6-7 patients were treated with no treatment (NT) or buprenorphine (Bup, 40μg/ml) in the presence of media or (A) the p65 NFκB inhibitor, BAY11-7085; (B) the <t>p38</t> <t>MAPK</t> inhibitor, SB203580; (C) the ERK inhibitor, SCH77298; or (D) the JNK inhibitor, SP600125. After 48hrs, cell-free supernatants were collected and measured by ELISA for IL-6, IL-8, IL-1β, G-CSF, PGE2, MMP1, and MMP9. * p <0.05 relative to NT/media or NT/inhibitor controls, or as otherwise indicated.
    P P38 Mapk, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p p38 mapk/product/Millipore
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    p p38 mapk - by Bioz Stars, 2024-12
    86/100 stars
      Buy from Supplier

    Image Search Results


    List of antibodies

    Journal: Cellular and Molecular Neurobiology

    Article Title: TMEM16A Activation Inhibits Autophagy in Dorsal Root Ganglion Cells, Which is Associated with the p38 MAPK/mTOR Pathway

    doi: 10.1007/s10571-024-01507-z

    Figure Lengend Snippet: List of antibodies

    Article Snippet: Rabbit Anti p-p38/MAPK (Thr180/Tyr182) (Proteintech) , 28796-1-AP , 1:2000.

    Techniques: Labeling

    ( A – C ) TMEM16A increases mRNA expression of p38 MAPK and mTOR (n = 10); ( D – H ) TMEM16A enhances protein expression of p38 MAPK and mTOR (n = 10). * Compared with control, P < 0.05; # Compared with NC+Rap, P < 0.05; +si-TMEM16A + Rap compared with TMEM16A+oe+Rap, P < 0.05

    Journal: Cellular and Molecular Neurobiology

    Article Title: TMEM16A Activation Inhibits Autophagy in Dorsal Root Ganglion Cells, Which is Associated with the p38 MAPK/mTOR Pathway

    doi: 10.1007/s10571-024-01507-z

    Figure Lengend Snippet: ( A – C ) TMEM16A increases mRNA expression of p38 MAPK and mTOR (n = 10); ( D – H ) TMEM16A enhances protein expression of p38 MAPK and mTOR (n = 10). * Compared with control, P < 0.05; # Compared with NC+Rap, P < 0.05; +si-TMEM16A + Rap compared with TMEM16A+oe+Rap, P < 0.05

    Article Snippet: Rabbit Anti p-p38/MAPK (Thr180/Tyr182) (Proteintech) , 28796-1-AP , 1:2000.

    Techniques: Expressing, Control

    Smpd3 mediates osteogenic differentiation of BMSCs through autophagy. a After pretreatment with 50 μmol/L GW4869 (Smpd3 inhibitor) for 1 h to inhibit Smpd3 in the presence or absence of CQ. b Treatment with 5 μmol/L GW4869 and Smpd3 knockdown lentivirus inhibited Smpd3 expression, and LC3 puncta were assessed using immunofluorescence analysis. Smpd3 inhibition reduced the formation of LC3 puncta (green dots in the figure). c Overexpression of Smpd3 increased autophagic flux. Smpd3 knockdown downregulated LC3 and upregulated P62, while overexpression of Smpd3 upregulated LC3 and downregulated P62. d Direct overexpression of Smpd3 can induce 50 μmol/L MCQ to inhibit LC3 autophagic flux and increase LC3 puncta. e Smpd3 knockdown inhibited the expression of p-p38 MAPK induced by 1xEBSS (autophagy inducer), while overexpression of Smpd3 activated the expression of p-p38 MAPK induced by 1xEBSS. f Smpd3 knockdown activated 1xEBSS-induced p-p38 MAPK expression, while overexpression of Smpd3 inhibited 1xEBSS-induced p-p38 MAPK expression. g , h After activation of autophagy with 1xEBSS, shSmpd3 increased bone formation at 7 days and ARS staining at 14 days. i , j There was no significant difference in ALP and calcium ion levels between the osteogenic induction group and the siControl group at 3 days and 14 days. k – n After inhibition of autophagy by 50 μmol/L CQ, Smpd3 overexpression increased in ALP staining at 7 days of bone induction and ARS staining at 14 days of bone induction, with significant difference in ALP quantification and calcium ion quantification at 3 days of bone induction compared to those of the vector group. o Smpd3-mediated autophagic induction is achieved by activating p38 MAPK, inhibiting mTOR and promoting osteogenic differentiation of BMSCs by inducing autophagy (scale bar = 50 μm, * P < 0.05, ** P < 0.01, *** P < 0.001, *** *P < 0.000 1 using one-way ANOVA and Student-Newman-Keuls test)

    Journal: International Journal of Oral Science

    Article Title: A blood glucose fluctuation-responsive delivery system promotes bone regeneration and the repair function of Smpd3-reprogrammed BMSC-derived exosomes

    doi: 10.1038/s41368-024-00328-6

    Figure Lengend Snippet: Smpd3 mediates osteogenic differentiation of BMSCs through autophagy. a After pretreatment with 50 μmol/L GW4869 (Smpd3 inhibitor) for 1 h to inhibit Smpd3 in the presence or absence of CQ. b Treatment with 5 μmol/L GW4869 and Smpd3 knockdown lentivirus inhibited Smpd3 expression, and LC3 puncta were assessed using immunofluorescence analysis. Smpd3 inhibition reduced the formation of LC3 puncta (green dots in the figure). c Overexpression of Smpd3 increased autophagic flux. Smpd3 knockdown downregulated LC3 and upregulated P62, while overexpression of Smpd3 upregulated LC3 and downregulated P62. d Direct overexpression of Smpd3 can induce 50 μmol/L MCQ to inhibit LC3 autophagic flux and increase LC3 puncta. e Smpd3 knockdown inhibited the expression of p-p38 MAPK induced by 1xEBSS (autophagy inducer), while overexpression of Smpd3 activated the expression of p-p38 MAPK induced by 1xEBSS. f Smpd3 knockdown activated 1xEBSS-induced p-p38 MAPK expression, while overexpression of Smpd3 inhibited 1xEBSS-induced p-p38 MAPK expression. g , h After activation of autophagy with 1xEBSS, shSmpd3 increased bone formation at 7 days and ARS staining at 14 days. i , j There was no significant difference in ALP and calcium ion levels between the osteogenic induction group and the siControl group at 3 days and 14 days. k – n After inhibition of autophagy by 50 μmol/L CQ, Smpd3 overexpression increased in ALP staining at 7 days of bone induction and ARS staining at 14 days of bone induction, with significant difference in ALP quantification and calcium ion quantification at 3 days of bone induction compared to those of the vector group. o Smpd3-mediated autophagic induction is achieved by activating p38 MAPK, inhibiting mTOR and promoting osteogenic differentiation of BMSCs by inducing autophagy (scale bar = 50 μm, * P < 0.05, ** P < 0.01, *** P < 0.001, *** *P < 0.000 1 using one-way ANOVA and Student-Newman-Keuls test)

    Article Snippet: The membrane was sealed with 5% dehydrated milk in TBS-T (20 mmol/L Tris HCl, pH 7.6, 150 mmol/L NaCl, 0.05% Tween 20) for 1 h and then incubated with the primary antibody at 4 °C for 24 h. The primary antibodies used were anti-Smpd3 (A10197; 1:1 000, ABclonal), anti-Runx2 (A2851; 1:1 000, ABclonal), anti-ALP (ab307726; 1:1 000, Abcam), anti-OCN (ab133612; 1:1 000, Abcam), anti- β-actin (AC038; 1:10 000, ABclonal), anti-P62 (sc-28359; 1:1 000, Santa Cruz), anti-LC3A/LC3B (A5618; 1:1 000, ABclonal), anti-p-p38 MAPK (AP0526,1:1 000, ABclonal), anti-p38 MAPK (A14401; 1:1 000, ABclonal), anti-p-mTOR (AP0115; 1:1 000, ABclonal), anti-mTOR (A2445; 1:1 000, ABclonal), anti-GAPDH (AC002); 1:10 000, ABclonal, anti-CD63 (A19023; 1:1 000, ABclonal), anti-CD9 (A19027; 1:1 000, ABclonal), anti-β- tubulin (AC008; 1:1 000, ABclonal), and anti-histone H3 (A2348; 1:1 000, ABclonal).

    Techniques: Knockdown, Expressing, Immunofluorescence, Inhibition, Over Expression, Activation Assay, Staining, Plasmid Preparation

    Human FM explants from 6-7 patients were treated with no treatment (NT) or buprenorphine (Bup, 40μg/ml) in the presence of media or (A) the p65 NFκB inhibitor, BAY11-7085; (B) the p38 MAPK inhibitor, SB203580; (C) the ERK inhibitor, SCH77298; or (D) the JNK inhibitor, SP600125. After 48hrs, cell-free supernatants were collected and measured by ELISA for IL-6, IL-8, IL-1β, G-CSF, PGE2, MMP1, and MMP9. * p <0.05 relative to NT/media or NT/inhibitor controls, or as otherwise indicated.

    Journal: bioRxiv

    Article Title: Buprenorphine Induces Human Fetal Membrane Sterile Inflammation

    doi: 10.1101/2024.11.22.624850

    Figure Lengend Snippet: Human FM explants from 6-7 patients were treated with no treatment (NT) or buprenorphine (Bup, 40μg/ml) in the presence of media or (A) the p65 NFκB inhibitor, BAY11-7085; (B) the p38 MAPK inhibitor, SB203580; (C) the ERK inhibitor, SCH77298; or (D) the JNK inhibitor, SP600125. After 48hrs, cell-free supernatants were collected and measured by ELISA for IL-6, IL-8, IL-1β, G-CSF, PGE2, MMP1, and MMP9. * p <0.05 relative to NT/media or NT/inhibitor controls, or as otherwise indicated.

    Article Snippet: Membranes were probed for the following primary antibodies all from Cell Signaling Technology (Danvers, MA): phosphorylated (p)-p65 NFκB (#3033; 1:1000); total (t)-p65 NFκB (#8242; 1:1000); p-p38 MAPK (#9211;1:500); t-p38 MAPK (#9212; 1:1000); p-ERK (#9101; 1:1000); t-ERK (#4695; 1:1000); p-JNK (#9251; 1:1000); t-JNK (#; 1:1000); Lamin B1 (#1343; 1:1000); p16 (#92803; 1:1000). β-Actin (A2066; 1:10000) from Sigma Aldrich was used as a loading control for Lamin B1 and p16.

    Techniques: Enzyme-linked Immunosorbent Assay